Free Trial
NASDAQ:IMTX

Immatics (IMTX) Stock Price, News & Analysis

Immatics logo
$5.28 -0.12 (-2.22%)
Closing price 08/28/2025 04:00 PM Eastern
Extended Trading
$5.27 -0.01 (-0.19%)
As of 08/28/2025 05:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Immatics Stock (NASDAQ:IMTX)

Key Stats

Today's Range
$5.24
$5.52
50-Day Range
$5.23
$6.68
52-Week Range
$3.30
$13.09
Volume
324,860 shs
Average Volume
639,308 shs
Market Capitalization
$641.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.67
Consensus Rating
Moderate Buy

Company Overview

Immatics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
48th Percentile Overall Score

IMTX MarketRank™: 

Immatics scored higher than 48% of companies evaluated by MarketBeat, and ranked 669th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Immatics has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 4 buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Immatics has only been the subject of 1 research reports in the past 90 days.

  • Read more about Immatics' stock forecast and price target.
  • Earnings Growth

    Earnings for Immatics are expected to decrease in the coming year, from ($0.72) to ($1.22) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Immatics is -8.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Immatics is -8.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Immatics has a P/B Ratio of 1.22. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Immatics' valuation and earnings.
  • Percentage of Shares Shorted

    3.16% of the float of Immatics has been sold short.
  • Short Interest Ratio / Days to Cover

    Immatics has a short interest ratio ("days to cover") of 6.3.
  • Change versus previous month

    Short interest in Immatics has recently decreased by 3.13%, indicating that investor sentiment is improving.
  • Dividend Yield

    Immatics does not currently pay a dividend.

  • Dividend Growth

    Immatics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.16% of the float of Immatics has been sold short.
  • Short Interest Ratio / Days to Cover

    Immatics has a short interest ratio ("days to cover") of 6.3.
  • Change versus previous month

    Short interest in Immatics has recently decreased by 3.13%, indicating that investor sentiment is improving.
  • News Sentiment

    Immatics has a news sentiment score of 1.28. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Immatics this week, compared to 3 articles on an average week.
  • Search Interest

    Only 1 people have searched for IMTX on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.
  • MarketBeat Follows

    Only 3 people have added Immatics to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Immatics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.30% of the stock of Immatics is held by insiders.

  • Percentage Held by Institutions

    64.41% of the stock of Immatics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Immatics' insider trading history.
Receive IMTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Immatics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IMTX Stock News Headlines

Leerink Partnrs Has Negative Outlook of Immatics Q3 Earnings
This stock could leave NVDA in the dust
Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.tc pixel
FY2025 EPS Estimates for Immatics Cut by Cantor Fitzgerald
See More Headlines

IMTX Stock Analysis - Frequently Asked Questions

Immatics' stock was trading at $7.11 at the beginning of 2025. Since then, IMTX stock has decreased by 25.7% and is now trading at $5.28.

Immatics N.V. (NASDAQ:IMTX) released its quarterly earnings data on Wednesday, August, 13th. The company reported ($0.66) earnings per share for the quarter, missing analysts' consensus estimates of ($0.38) by $0.28. The business had revenue of $6.48 million for the quarter, compared to analysts' expectations of $13.05 million. Immatics had a negative trailing twelve-month return on equity of 15.60% and a negative net margin of 59.29%.

Top institutional shareholders of Immatics include Vestal Point Capital LP (5.14%), Sofinnova Investments Inc. (1.84%), Wasatch Advisors LP (0.65%) and Orbimed Advisors LLC (0.59%).

Shares of IMTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Immatics investors own include Broadcom (AVGO), Datadog (DDOG), Advanced Micro Devices (AMD), Moderna (MRNA), Cloudflare (NET) and QUALCOMM (QCOM).

Company Calendar

Last Earnings
8/13/2025
Today
8/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:IMTX
CIK
1809196
Fax
N/A
Employees
260
Year Founded
N/A

Price Target and Rating

High Price Target
$19.00
Low Price Target
$10.00
Potential Upside/Downside
+177.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.65)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$16.47 million
Net Margins
-59.29%
Pretax Margin
-56.82%
Return on Equity
-15.60%
Return on Assets
-12.31%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
8.80
Quick Ratio
8.80

Sales & Book Value

Annual Sales
$168.65 million
Price / Sales
3.81
Cash Flow
$0.24 per share
Price / Cash Flow
22.10
Book Value
$4.34 per share
Price / Book
1.22

Miscellaneous

Outstanding Shares
121,550,000
Free Float
117,539,000
Market Cap
$641.78 million
Optionable
Optionable
Beta
0.93
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:IMTX) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners